Follow Us:

This online educational activity is directed toward ophthalmologists, optometrists and other healthcare professionals who would be involved in dry eye disease care, such as PCPs, NPs and PAs.
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED), with a forward-looking perspective on how new and novel agents may impact clinical practice. An overview of MGD and its association with DED as well as current and emerging treatment strategies will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.
Upon completion of this activity, participants should be better able to: